10/15/2024 13:24 – Inside information

Glucodent Ltd. has successfully completed the examination of the effect of the API on the growth and development (proliferation) of pathogenic bacteria in the oral cavity with positive results.

Download document

09/23/2024 11:14 – Inside information

Glucodent Ltd. has successfully completed the examination of the effect of the API on the pH of artificial saliva. The results obtained show that the action of the API exceeds the initial goals set by the scientists involved in the development of the GLUCODENT© product.

Download document

07/31/2024 12:42 – Inside information

Glucodent Ltd. and IQVIA have signed an agreement to develop a "Data Informed Protocol Assessment" for an oral pathology product in diabetics

Download document

07/15/2024 16:29 – Inside information

Glucodent Ltd. has successfully synthesized various APIs to form the basis for further research on the medical product for treating oral pathology in diabetics.

Download document